Kidney Thrombotic Microangiopathy After COVID-19 Associated With C3 Gene Mutation
Olivier Mat, Lidia Ghisdal, Annick Massart and 6 more
Kidney International Reports · 2021
doi:10.1016/j.ekir.2021.03.897 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Acute kidney injury (AKI) is not uncommon in patients with coronavirus disease 2019 (COVID-19), but thrombotic microangiopathy (TMA) linked to COVID-19 has been exceptionally reported in another patient.1 However, COVID-19–infected patients can develop proteinuria (44%), hematuria (27%), or AKI (5.1%).2 We report a case of atypical hemolytic uremic syndrome (aHUS) associated with COVID-19. This case highlights the importance of a rapid diagnosis, a good medical history, and a genetic analysis to optimize the management of this rare disease.
Abstract licence: CC BY-NC-ND
References10
10 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.